Rob Winn Appointed Director of NCI-Designated Fox Chase Cancer Center

oncodaily - Fox Chase Cancer Center shared a post on LinkedIn: “Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center […]

AI Summary: Rob Winn has been appointed director of the NCI‑designated Fox Chase Cancer Center, taking the reins of clinical, research and strategic operations. His role will focus on strengthening translational research, patient care integration and institutional partnerships to advance the center's mission — you know, the usual: cure more cancer, argue less in committee meetings.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

High‑dose targeted radiation shows promise for huge bile duct tumors / 1 month

Introducing ISCO 2026 chairs and program highlights / 5 wks

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 11 days

ESMO issues new metastatic colorectal cancer clinical guideline / 6 wks

Bowelbabe Fund reaches £20M and announces vaccine initiative / 1 month

AACR names 2026 Distinguished Service Award recipients / 6 wks

Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 2 months